Cargando…
Whole Blood DNA Aberrant Methylation in Pancreatic Adenocarcinoma Shows Association with the Course of the Disease: A Pilot Study
Pancreatic tumors are usually diagnosed at an advanced stage in the progression of the disease, thus reducing the survival chances of the patients. Non-invasive early detection would greatly enhance therapy and survival rates. Toward this aim, we investigated in a pilot study the power of methylatio...
Autores principales: | Dauksa, Albertas, Gulbinas, Antanas, Barauskas, Giedrius, Pundzius, Juozas, Oldenburg, Johannes, El-Maarri, Osman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358256/ https://www.ncbi.nlm.nih.gov/pubmed/22629410 http://dx.doi.org/10.1371/journal.pone.0037509 |
Ejemplares similares
-
Detailed methylation map of LINE‐1 5′‐promoter region reveals hypomethylated CpG hotspots associated with tumor tissue specificity
por: Sharma, Amit, et al.
Publicado: (2019) -
DNA Methylation of HOXA11 Gene as Prognostic Molecular Marker in Human Gastric Adenocarcinoma
por: Ignatavicius, Povilas, et al.
Publicado: (2022) -
Inter-locus as well as intra-locus heterogeneity in LINE-1 promoter methylation in common human cancers suggests selective demethylation pressure at specific CpGs
por: Nüsgen, Nicole, et al.
Publicado: (2015) -
Dynamic perfusion CT – A promising tool to diagnose pancreatic ductal adenocarcinoma
por: Zaborienė, Inga, et al.
Publicado: (2021) -
Transaxillary gasless endoscopic thyroidectomy versus conventional open thyroidectomy: systematic review and meta-analysis
por: Jasaitis, Kristijonas, et al.
Publicado: (2021)